Protalix BioTherapeutics, Inc. (NYSE:PLX) announced a collaboration with the Germany-based Secarna Pharmaceuticals to develop novel antisense oligonucleotide (ASO) therapies using Secarna’s ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

Have you ever spent hours crafting a timeline chart, only to abandon it because it was too clunky, rigid, or just plain uninspiring? You’re not alone. Many tools promise sleek visuals but fall short ...

Imagine transforming hours of tedious data work into mere minutes of productivity. That’s the promise of Microsoft Copilot in Excel, a new AI-powered assistant designed to transform how you manage, ...

Protalix BioTherapeutics, Inc. (NYSE:PLX) announced 3Q:25 financial and operational results in a November 13th, 2025, press release and in its Form 10-Q filing. The reports were followed by a ...

I’ve spent the past few years trying to understand something that often feels beyond understanding—how artificial intelligence, particularly large language models, actually thinks. Or at least, how ...

Fabry disease is a rare genetic lysosomal storage disorder in which the body lacks sufficient amounts of an enzyme that breaks down fats. The companies requested to approve the dosing regimen of 2 ...

DEER PARK, N.Y.--(BUSINESS WIRE)--Luxium Solutions, LLC (“Luxium” or the “Company”), a worldwide technology leader and provider of high-performance crystals used in photonics and radiation detection ...

Plexium has raised $60.1 million, providing an infusion of cash for the recently slimmed-down protein degrader specialist three years on from its breakout year. The biotech put itself on the map in ...

Protalix BioTherapeutics uses a plant-cell approach with ProCellEx. This has given it two approved ERTs plus PRX-115 and PRX-119. Its main focus is on a growing rare-disease pipeline. The main value ...

ALL NEW THIS AFTERNOON. THE CAMERAS ARE ROLLING ON ANOTHER BIG TV SHOW FILMING HERE IN OUR AREA COVERING ALLEGHENY COUNTY. PITTSBURGH’S ACTION NEWS FOUR REPORTER LILY COLEMAN WAS THERE AS CREWS WERE ...

Good morning, ladies and gentlemen, and welcome to the Protalix BioTherapeutics Second Quarter 2025 Financial and Business Results Conference Call. As a reminder, this conference is being recorded. I ...